Advances in the management of conjunctival melanoma

被引:95
作者
Vora, Gargi K. [1 ]
Demirci, Hakan [2 ]
Marr, Brian [3 ]
Mruthyunjaya, Prithvi [1 ]
机构
[1] Duke Univ, Dept Ophthalmol, Durham, NC USA
[2] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA
[3] Weill Cornell Med Sch, Ophthalm Oncol Serv, Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY USA
关键词
conjunctival melanoma; malignant melanoma of the conjunctiva; PRIMARY ACQUIRED MELANOSIS; LYMPH-NODE BIOPSY; TOPICAL MITOMYCIN-C; AMELANOTIC MALIGNANT-MELANOMA; AMERICAN JOINT COMMITTEE; OCULAR MELANOMA; COPY NUMBER; ULTRASOUND BIOMICROSCOPY; CHEMOTHERAPEUTIC-AGENTS; PROGNOSTIC-SIGNIFICANCE;
D O I
10.1016/j.survophthal.2016.06.001
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Malignant melanoma of the conjunctiva is a rare but serious condition. Over the last several years, there have been important advances in the classification, diagnosis, and treatment of this condition. Recent cytogenetic and immunohistochemical studies are increasing understanding of its tumorigenesis. Diagnosis, although still made via histopathology, has been aided with imaging techniques such as ultrasound biomicroscopy and anterior segment optical coherence tomography. Primary treatment consists of surgical excision. But adjuvant treatments with cryotherapy, topical chemotherapy, and radiation therapy have shown increased success. Sentinel lymph node biopsy has shown early promise of detecting micro-metastasis. Long term follow-up of patients with conjunctival melanoma with systemic surveillance is necessary to detect recurrences and metastases. Published by Elsevier Inc.
引用
收藏
页码:26 / 42
页数:17
相关论文
共 167 条
[41]   Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia [J].
FruchtPery, J ;
Peer, J .
ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (10) :1261-1264
[42]   BRAF mutations in conjunctival melanoma [J].
Gear, J ;
Willimas, H ;
Kemp, EG ;
Roberts, F .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (08) :2484-2488
[43]   Orbital foreign body masquerading as conjunctival melanoma 60 years after injury [J].
Gelston, CD ;
Mandava, N ;
Durairaj, VD .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 33 (06) :661-663
[44]  
GLOOR P, 1995, INVEST OPHTH VIS SCI, V36, P1721
[45]   T1799A BRAF mutations in conjunctival melanocytic lesions [J].
Goldenberg-Cohen, N ;
Cohen, Y ;
Rosenbaum, E ;
Herscovici, Z ;
Chowers, I ;
Weinberger, D ;
Pe'er, J ;
Sidransky, D .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (09) :3027-3030
[46]   Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas [J].
Griewank, Klaus G. ;
Westekemper, Henrike ;
Murali, Rajmohan ;
Mach, Monika ;
Schilling, Bastian ;
Wiesner, Thomas ;
Schimming, Tobias ;
Livingstone, Elisabeth ;
Sucker, Antje ;
Grabellus, Florian ;
Metz, Claudia ;
Suesskind, Daniela ;
Hillen, Uwe ;
Speicher, Michael R. ;
Woodman, Scott E. ;
Steuhl, Klaus-Peter ;
Schadendorf, Dirk .
CLINICAL CANCER RESEARCH, 2013, 19 (12) :3143-3152
[47]  
Grove A S Jr, 1980, Int Ophthalmol Clin, V20, P161
[48]   The use of ultrasound biomicroscopy in the evaluation of anterior segment tumors and simulating conditions [J].
Guenduez, Kaan ;
Hosal, Banu M. ;
Zilelioglu, Gueler ;
Guenalp, Ilhan .
OPHTHALMOLOGICA, 2007, 221 (05) :305-312
[49]  
Guy J R, 1985, Cornea, V4, P263
[50]   Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation [J].
Hamai, A. ;
Richon, C. ;
Meslin, F. ;
Faure, F. ;
Kauffmann, A. ;
Lecluse, Y. ;
Jalil, A. ;
Larue, L. ;
Avril, M. F. ;
Chouaib, S. ;
Mehrpour, M. .
ONCOGENE, 2006, 25 (58) :7618-7634